Literature DB >> 16949476

Mimicks of pancreatic malignancy in patients with chronic pancreatitis: correlation of computed tomography imaging features with histopathologic findings.

Aytekin Oto1, Mahmoud A Eltorky, Amish Dave, Randy D Ernst, Keven Chen, Bill Rampy, Gregory Chaljub, William Nealon.   

Abstract

Differentiation of chronic pancreatitis and pancreatic carcinoma can be a clinical and radiologic dilemma. Several patients with chronic pancreatitis can undergo unnecessary major abdominal surgery for benign lesions. This pictorial review illustrates the computed tomographic findings and histopathologic features of lesions mimicking pancreatic neoplasm in patients with chronic pancreatitis. Several benign lesions can simulate pancreatic malignancy in patients with chronic pancreatitis. Knowledge of the computed tomographic appearance of these benign entities is important to prevent unnecessary surgeries.

Entities:  

Mesh:

Year:  2006        PMID: 16949476     DOI: 10.1067/j.cpradiol.2006.06.001

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  10 in total

1.  Plectin-1 as a novel biomarker for pancreatic cancer.

Authors:  Dirk Bausch; Stephanie Thomas; Mari Mino-Kenudson; Castillo Carlos Fernández-del; Todd W Bauer; Mark Williams; Andrew L Warshaw; Sarah P Thayer; Kimberly A Kelly
Journal:  Clin Cancer Res       Date:  2010-11-23       Impact factor: 12.531

Review 2.  Molecular markers of pancreatic cancer: development and clinical relevance.

Authors:  Lucia C Fry; Klaus Mönkemüller; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2008-02-12       Impact factor: 3.445

Review 3.  Head mass in chronic pancreatitis: Inflammatory or malignant.

Authors:  Amit K Dutta; Ashok Chacko
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

4.  PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.

Authors:  David V Gold; Jochen Gaedcke; B Michael Ghadimi; Michael Goggins; Ralph H Hruban; Mengling Liu; Guy Newsome; David M Goldenberg
Journal:  Cancer       Date:  2012-08-16       Impact factor: 6.860

5.  Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.

Authors:  Venkata Subramanian Krishnaraju; Rajender Kumar; Bhagwant Rai Mittal; Vishal Sharma; Harjeet Singh; Ritambhra Nada; Amanjit Bal; Manish Rohilla; Harmandeep Singh; Surinder S Rana
Journal:  Eur Radiol       Date:  2020-10-01       Impact factor: 5.315

6.  Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.

Authors:  Chanjuan Shi; Nipun Merchant; Guy Newsome; David M Goldenberg; David V Gold
Journal:  Arch Pathol Lab Med       Date:  2014-02       Impact factor: 5.534

7.  Secretome-based identification of ULBP2 as a novel serum marker for pancreatic cancer detection.

Authors:  Ya-Ting Chang; Chih-Ching Wu; Yi-Ming Shyr; Tse-Ching Chen; Tsann-Long Hwang; Ta-Sen Yeh; Kai-Ping Chang; Hao-Ping Liu; Yu-Ling Liu; Ming-Hung Tsai; Yu-Sun Chang; Jau-Song Yu
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

Review 8.  Plectin in Cancer: From Biomarker to Therapeutic Target.

Authors:  Samantha M Perez; Lindsey T Brinton; Kimberly A Kelly
Journal:  Cells       Date:  2021-08-30       Impact factor: 6.600

Review 9.  Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).

Authors:  Isaac R Francis
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

Review 10.  K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis.

Authors:  Jing Yang; Jingjing Li; Rong Zhu; Huawei Zhang; Yuanyuan Zheng; Weiqi Dai; Fan Wang; Miao Shen; Kan Chen; Ping Cheng; Yan Zhang; Chengfen Wang; Junshan Wang; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Dis Markers       Date:  2014-07-16       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.